All Updates

All Updates

icon
Filter
Partnerships
Funding
N-Power raises undisclosed Series B funding
Clinical Trial Technology
Jul 1, 2024
This week:
Partnerships
MGI Tech and Predica Diagnostics collaborate to develop Predica's targeted RNA sequencing tests
Precision Medicine
Yesterday
Partnerships
Renalytix partners with Steno Diabetes Center to advance precision medicine solutions for diabetes and chronic kidney disease
Precision Medicine
Yesterday
Partnerships
Myriad Genetics and Personalis cross-license patents for tumor-informed cancer treatment tests
Precision Medicine
Yesterday
Funding
Element Biosciences raises USD 277 million in Series D funding to commercialize AVITI DNA sequencer and support AVITI24 launch
Precision Medicine
Yesterday
Funding
Jacobi Robotics raises USD 5 million in seed funding to expand capacity
Smart Factory
Yesterday
M&A
Formlabs acquires Micronics for undisclosed sum to develop next-generation SLS printers
Additive Manufacturing
Yesterday
Partnerships
Anthropic partners with Amazon Bedrock to fine-tune Claude 3 Haiku model
Foundation Models
Yesterday
Funding
Lemon.markets raises EUR 12 million in funding to support growth
FinTech Infrastructure
Yesterday
M&A
Kipu Quantum acquires PlanQK platform to enhance accessibility to quantum computing solutions
Quantum Computing
Yesterday
Partnerships
Quantinuum and STFC Hartree Centre partner to enhance quantum computing accessibility in UK
Quantum Computing
Yesterday
Clinical Trial Technology

Clinical Trial Technology

Jul 1, 2024

N-Power raises undisclosed Series B funding

Partnerships
Funding

  • N-Power Medicine, a provider of a platform for clinical trials, has raised an undisclosed sum in a Series B funding round led by Merck Global Health Innovation Fund, with participation from a US-based healthcare-focused investor. This brings the total funds raised by the company to USD 72 million.

  • The raised funds will be used to expand N-Power's oncology clinic network. By year-end, N-Power plans to partner with six to eight oncology clinics and expects to have more than 100 oncologists in its network.

  • In addition to the funding, N-Power partnered with Merck to expand access to clinical trials for oncologists and patients. Through the partnership, Merck's clinical trials will be available across N-Power’s network sites, with two initial trials currently available.

  • Based in California, N-Power Medicine focuses on transforming clinical trials in oncology through its purpose-built clinical research platform. The company's main offering, the N-Power Platform, aims to accelerate drug development by enabling community oncology practices to conduct clinical trials more effectively by integrating research and standard care into a single workflow. N-Power additionally provides on-site and virtual staffing to support clinical research operations.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.